Applied Therapeutics Inc (APLT)
9.625
+0.36
(+3.83%)
USD |
NASDAQ |
Nov 22, 16:00
9.39
-0.24
(-2.44%)
After-Hours: 20:00
Applied Therapeutics Cash from Investing (Quarterly): 0.00 for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 13.87M |
| December 31, 2022 | -6.905M |
| September 30, 2022 | 5.021M |
| June 30, 2022 | 5.529M |
| March 31, 2022 | 9.525M |
| December 31, 2021 | 11.81M |
| September 30, 2021 | 8.518M |
| Date | Value |
|---|---|
| June 30, 2021 | 16.78M |
| March 31, 2021 | -24.67M |
| December 31, 2020 | 28.44M |
| September 30, 2020 | -30.25M |
| June 30, 2020 | 24.04M |
| March 31, 2020 | -41.71M |
| December 31, 2019 | -0.128M |
| September 30, 2019 | -19.88M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-41.71M
Minimum
Mar 2020
28.44M
Maximum
Dec 2020
0.9939M
Average
--
Median
Jun 2023
Cash from Investing (Quarterly) Benchmarks
| ResMed Inc | 2.146M |
| Axonics Inc | 70.13M |
| Organon & Co | -75.00M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -23.33M |
| Free Cash Flow | -81.84M |
| Free Cash Flow Per Share (Quarterly) | -0.1616 |
| Free Cash Flow to Equity (Quarterly) | -23.33M |
| Free Cash Flow Yield | -6.39% |